Abstract
Within the last 3 years, genome-wide association studies (GWAS) have had unprecedented success in identifying loci that are involved in common diseases. For example, more than 35 susceptibility loci have been identified for type 2 diabetes and 32 for obesity thus far. However, the causal gene and variant at a specific linkage disequilibrium block is often unclear. Using a combination of different mouse alleles, we can greatly facilitate the understanding of which candidate gene at a particular disease locus is associated with the disease in humans, and also provide functional analysis of variants through an allelic series, including analysis of hypomorph and hypermorph point mutations, and knockout and overexpression alleles. The phenotyping of these alleles for specific traits of interest, in combination with the functional analysis of the genetic variants, may reveal the molecular and cellular mechanism of action of these disease variants, and ultimately lead to the identification of novel therapeutic strategies for common human diseases. In this Commentary, we discuss the progress of GWAS in identifying common disease loci for metabolic disease, and the use of the mouse as a model to confirm candidate genes and provide mechanistic insights.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
Review – Mouse models of metastasis: progress and prospects
Currently available mouse models of metastasis are reviewed by Valerie G. Brunton and colleagues, with a focus on the mechanistic and therapeutic insights that have been gained by their application, strengths and weaknesses of different models and key technological advances that are generating more refined models.
Perspective – Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
Victorio M. Pozo Devoto and Tomas L. Falzone review the α-synuclein structural, biophysical and biochemical properties that influence relevant mitochondrial physiological processes such as fusion-fission, transport and clearance, and propose that α-synuclein contributes to the mitochondrial defects that are associated with Parkinson's disease.
Editors’ choice – Loss of Cln5 causes altered neurogenesis in a mouse model of a childhood neurodegenerative disorder
In our latest Editors' choice article, Katja M. Kanninen and colleagues examine neurogenesis in the neuronal ceroid lipofuscinoses – neurodegenerative disorders caused by loss of the Cln5 gene – and report a novel function of the CLN5 protein.
Call for papers: Cancer metabolism special collection
DEADLINE EXTENDED TO MONDAY 16TH OCTOBER 2016
DMM invites you to submit original research for a special collection focused on the dysregulation of metabolic pathways in cancer initiation, progression and resistance to treatment. This ongoing collection will be launched with a special issue scheduled for publication in spring 2018, with the special issue guest edited by Almut Schulze (University of Würzberg, Germany) and Mariia Yuneva (Crick Institute, London, UK).
Find out more here.
First person – Lucía Zacchi
We continue our new series of interviews with the first authors of articles published in DMM, giving authors the opportunity to promote themselves alongside their papers. In this issue we feature Lucía Zacchi, first author on a Resource article describing a novel yeast screen to identify genetic modifiers of protein levels in dystonia.